While liquid biopsies are best known for oncology, their potential extends to other medical fields, driving market diversification. Innovators are exploring uses in prenatal care (detecting fetal genetic disorders), transplant monitoring (tracking organ rejection), and autoimmune disease management (identifying inflammatory biomarkers). These applications, though nascent, are projected to...